Industry pessimistic about future of research and development in UK
Pharmaceutical companies are pessimistic about the industry’s future in the UK, a survey has revealed.
Of 100 UK-based pharmaceutical companies questioned as part of research
by the Association of the British Pharmaceutical Industry and the Confederation
of British Industry, 97 per cent said there is now an increasing level
of uncertainty within the UK pharmaceutical market environment. Three
quarters said they had little confidence in the current environment.
Only 1 per cent expected it to improve while 83 per cent expected it
to deteriorate.
In addition, around a third of companies also expected to reduce the
level of research and development that is undertaken in the UK and 46
per cent expected to reduce the number of clinical trials that are undertaken
in the UK.
Nigel Brooksby, president of the ABPI, said that the Government and the
pharmaceutical industry must work together urgently to restore business
trust and planning stability, so that the UK can return to providing
an environment where global companies have the confidence to invest.
|
The
Pharmaceutical Journal
Acrobat
Reader